Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies

Fusco, D., Malenica, I., Günthard, H. F., Gupta, S. K., Kurbegov, D., Balani, B., Olender, S., Aberg, J. A., Telep, L. E., Tian, Y., Blair, C., Wu, G., Haubrich, R. H., Wang, C.-Y., Chokkalingam, A. P., Osinusi, A. O., Wendtner, C.-M., & Gottlieb, R. L. (2024). Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison From 2 Large, Open-Label Studies. Clinical Infectious Diseases, 79(5), 1182–1189. https://doi.org/10.1093/cid/ciae336
Authors:
Dahlene Fusco
Ivana Malenica
Huldrych F Günthard
Samir K Gupta
Dax Kurbegov
Bindu Balani
Susan Olender
Judith A Aberg
Laura E Telep
Yuan Tian
Christiana Blair
George Wu
Richard H Haubrich
Chen-Yu Wang
Anand P Chokkalingam
Anu O Osinusi
Clemens-Martin Wendtner
Robert L Gottlieb
Affiliated Authors:
Susan Olender
Columbia Affiliation:
Subjects:
Adenosine Monophosphate (MeSH)
Alanine (MeSH)
Antiviral Agents (MeSH)
COVID-19 (MeSH)
COVID-19 Drug Treatment (MeSH)
SARS-CoV-2 (MeSH)
Author Keywords:
sars-cov-2
antiviral
discharge
hospitalization
mortality
elink
Publication Type:
Article
Unique ID:
10.1093/cid/ciae336
PMID:
38920297
DOI:
10.1093/cid/ciae336
Journal:
Clinical Infectious Diseases
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: